Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 793,626 | 586,921 | 708,759 | 859,126 | 489,631 |
Marketable Securities | 2,765,213 | 3,322,898 | 3,657,607 | 2,118,647 | 2,292,437 |
Receivables | 2,653,167 | 2,172,875 | 1,870,733 | 2,090,563 | 1,661,757 |
Inventories | 2,050,554 | 1,671,442 | 1,394,334 | 1,186,779 | 1,327,623 |
Other current assets | 907,859 | 927,920 | 841,731 | 387,591 | 621,408 |
TOTAL | $9,170,419 | $8,682,056 | $8,473,164 | $6,642,706 | $6,392,856 |
Non-Current Assets | |||||
PPE Net | 9,595,940 | 7,820,528 | 6,515,812 | 5,717,653 | 5,139,190 |
Investments And Advances | 221,615 | 158,806 | 106,550 | 69,371 | 72,892 |
Other Non-Current Assets | 188,315 | 159,124 | 150,200 | 79,938 | 55,469 |
TOTAL | $10,005,870 | $8,138,458 | $6,772,562 | $5,866,962 | $5,267,551 |
Total Assets | $19,176,290 | $16,820,510 | $15,245,730 | $12,509,670 | $11,660,410 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 128,121 | 3,650 | 55,866 | 74,355 | 108,923 |
Accounts payable and accrued liabilities | 931,585 | 994,175 | 741,344 | 654,634 | 592,363 |
Other current liabilities | 1,628,975 | 1,317,905 | 1,303,123 | 1,385,042 | 936,479 |
TOTAL | $3,678,506 | $3,432,856 | $3,849,597 | $4,171,319 | $3,647,043 |
Non-Current Liabilities | |||||
Long Term Debt | 3,332,833 | 2,593,940 | 1,710,804 | 1,141,447 | 1,563,928 |
aiOther Non-Current Liabilities | 250,751 | 210,092 | 200,923 | 163,207 | 189,965 |
TOTAL | $3,583,584 | $2,804,032 | $1,911,727 | $1,304,654 | $1,753,893 |
Total Liabilities | $7,262,090 | $6,236,888 | $5,760,791 | $5,475,973 | $5,400,936 |
Shareholders' Equity | |||||
Common Shares | 750,292 | 750,292 | 747,462 | 632,508 | 632,508 |
Retained earnings | 8,514,374 | 7,183,715 | 6,116,919 | 4,840,398 | 4,057,993 |
Other shareholders' equity | 5 | 110,121 | 95,174 | 1,560,789 | 1,568,970 |
TOTAL | $11,914,200 | $10,583,630 | $9,484,402 | $7,033,695 | $6,259,471 |
Total Liabilities And Equity | $19,176,290 | $16,820,518 | $15,245,193 | $12,509,668 | $11,660,407 |